Effect of timing of lymphokine presentation on generation of cytotoxic T lymphocytes.

Encouraging results of clinical trials with interleukin 2 therapy for advanced malignant neoplasms have led to efforts to reduce the toxicity and improve the efficacy of tumor immunotherapy. To begin to achieve this goal, we studied the lymphokine requirements for in vitro generation of polyclonal cytotoxic T lymphocytes (CTL) from C57BL/6 murine thymocytes. We found that both interleukin 2 and interleukin 6 are required for optimal generation of CTL from murine thymocytes. Timing studies show that neither lymphokine alone in culture will produce maximum CTL levels during the first 84 hours of culture. In addition, we found that thymocytes cultured with concanavalin A are unresponsive unless either interleukin 2 or interleukin 6 is present from the onset of culture.

[1]  R. Kriz,et al.  Stimulation of murine hemopoietic colony formation by human IL-6. , 1988, Journal of immunology.

[2]  C. Uyttenhove,et al.  T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor , 1988, The Journal of experimental medicine.

[3]  A. Singer,et al.  Intrathymic differentiation and tolerance induction of lymphokine-secreting Lyt-2+ T helper cells. , 1988, Journal of immunology.

[4]  T. Hirano,et al.  B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes , 1988, The Journal of experimental medicine.

[5]  S. Clark,et al.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. , 1988, Journal of immunology.

[6]  S. Clark,et al.  B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Rosenberg,et al.  Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. , 1987, Journal of immunology.

[8]  S. Rosenberg,et al.  Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. , 1987, Journal of immunology.

[9]  J. Thompson,et al.  Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory. , 1987, Journal of immunology.

[10]  K. Grabstein,et al.  Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor , 1987, Nature.

[11]  S. Rosenberg,et al.  In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice. , 1987, Cancer research.

[12]  R. Schwartz,et al.  T‐Cell Unresponsiveness in vivo and in vitro: Fine Specificity of Induction and Molecular Characterization of the Unresponsive State , 1987, Immunological reviews.

[13]  S. Herrmann,et al.  Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes. , 1986, Journal of immunology.

[14]  K. Okuno,et al.  Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. I. Requirement of both killer-helper factor(s) and interleukin 2 for CTL generation from a subpopulation of thymocytes. , 1986, Journal of immunology.

[15]  H. Eisen,et al.  Isolation and partial characterization of concanavalin A receptors on cloned cytotoxic T lymphocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Scheurich,et al.  Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. , 1982 .

[17]  M. Bevan,et al.  A differentiation factor required for the expression of cytotoxic T-cell function , 1982, Nature.

[18]  C. Henney,et al.  The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. , 1981, Journal of immunology.

[19]  M. Röllinghoff,et al.  T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity , 1978, The Journal of experimental medicine.